BioStrand (a subsidiary of IPA)

IPA (ImmunoPrecise Antibodies) Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSᵃⁱ™ Technology The 2024 Impact Award, sponsored by InterSystems, acknowledges BioStrand’s innovative LENSᵃⁱ technology, selected from over 1,000 client projects for its remarkable contributions. The selection committee, chaired by Professor Roberto Zicari, identified BioStrand’s work based on three key criteria: makes a significant difference, breaks new ground and sets an example. Tune in to today's Main Stage live to see the award presentation from 10:30-11:00am ET : https://lnkd.in/dJ3uhRyc See the full release: https://lnkd.in/evKm9qpQ #VectorSearch #DrugDiscovery #BioTech #Antibodies #LENSai

#AI is no longer just a buzzword in #lifesciences.   At BioTechX 2024, it was clear how AI is transforming clinical trials, personalized medicine, and molecular engineering. It’s not just about speeding things up—it’s about driving better outcomes across the board.   However, a key challenge remains: aligning biological insights with AI applications and seamlessly integrating complex datasets to unlock even greater potential.   Curious how BioStrand can help here? Check out the full blog: https://lnkd.in/emssNXzu #BioStrandBlogs #BioTechX2024 #DataIntegration

How does in silico #epitopemapping compare to traditional X-ray crystallography? In our latest #casestudy, we explore the 6RPS crystal complex and evaluate both methods. LENSᵃⁱ™'s advanced #insilico platform demonstrated strong alignment with the accuracy of X-ray crystallography, while offering high-throughput results in a fraction of the time. This underscores the potential of in silico technologies to enhance #antibodydiscovery workflows—improving efficiency, lowering costs, and accelerating timelines. #BioTech #TechBio #DrugDiscovery IPA (ImmunoPrecise Antibodies)

We’re at the Festival of Biologics! Visit us at booth #346 to see how we’re combining advanced AI with wet lab capabilities to drive #innovation in #antibodydiscovery. Together, we’re tackling complex challenges and accelerating research. Looking forward to meeting you! #FestivalofBiologics IPA (ImmunoPrecise Antibodies)

We’re gearing up for a busy season of conferences! #Bioinformatics is evolving rapidly, and AI is driving much of that change. At BioStrand, we’re helping researchers tackle complex data challenges and accelerate #drugdiscovery with AI-driven solutions. Check out our new #blog for a look at our upcoming events and let’s connect to discuss how we can support your research needs: https://lnkd.in/evUcKXVM #AntibodyDiscovery IPA (ImmunoPrecise Antibodies)

Arnout Van Hyfte just wrapped up his talk at BioTechX! He shared how the LENSᵃⁱ™ platform is streamlining antibody discovery by integrating data for smarter, faster decision-making. We’re also running live demos at booth #922 —come by, see our tech in action, and let’s chat about how we can tackle your data challenges together. #BioTechX #AntibodyDiscovery #DataIntegration #AI #Bioinformatics

BioTechX has officially kicked off! We're excited to be at Europe’s largest pharma and healthcare event today and tomorrow, October 9-10, in Basel. Our team—Dirk Van Hyfte, Ingrid Brands, and Arnout Van Hyfte—is ready to discuss how we can help you tackle complex datasets with our innovative solutions. Stop by booth #922 to meet the team and catch our live #demo, where we’ll showcase how our technology can help solve your toughest challenges. Don’t miss this opportunity to see our solutions in action. We’re looking forward to seeing you! #BioTechX #DataIntegration #PersonalizedTherapies #AI #Bioinformatics IPA (ImmunoPrecise Antibodies)

BioTechX is just around the corner, and we’re excited to be part of it on October 9-10! Don’t miss Arnout Van Hyfte’s talk, “Streamlining Antibody Discovery: Integrating Data for Smarter Candidate Selection”, where he will showcase the LENSᵃⁱ™ platform, designed to deliver deep, scalable insights for faster, informed decisions. Presentation: Streamlining Antibody Discovery: Integrating Data for Smarter Candidate Selection When: Thursday, October 10 | 12:05 PM – 12:25 PM Track: Bioinformatics + In silico R&D We’ll also be at booth #922 throughout the event—come by to connect with our team and explore how we can help you with complex datasets. #BioTechX2024 #DataIntegration #Bioinformatics #AI

Data integration in #antibodydiscovery can feel like an overwhelming challenge—fragmented, complex, and slow. But it doesn’t have to be that way. Our LENSᵃⁱ™ Integrated Intelligence Platform eliminates guesswork and brings #multiomics data together at the subsequence level for sharper insights and faster decisions. Whether you’re discovering new targets or optimizing leads, we’ve got the tools to help you solve the complex. Ready to streamline your research? Let’s make it happen. https://lnkd.in/ehXUPWUj #LENSai #DrugDiscovery #DataIntegration

We’re heading to BioTechX Europe on October 9-10, and we'd love to see you there! Arnout Van Hyfte, our Head of Platform and Products, will be presenting "Solve the Complex: Enhanced Data Integration via LENSᵃⁱ™". Track: Bioinformatics + In silico R&D Booth: 922 In this session, you’ll learn how our LENSᵃⁱ platform simplifies data integration across multiple modalities, helping researchers make faster, more informed decisions. If you're working with complex datasets, this talk is for you. We’re also offering a limited number of FREE guest tickets, so don’t miss your chance to join us for two days of innovation and insights. Secure your free pass here: https://lnkd.in/eJPE8Q56 #BioTechX #BioStrand #DataIntegration #LENSai #Bioinformatics IPA (ImmunoPrecise Antibodies)